ヨーロッパのCBD製品市場:2028年までの予測

出版:Market Research Future(マーケットリサーチフューチャー) 出版年月:2022年9月

Europe CBD Products Market Research Report Forecast to 2028
ヨーロッパのCBD製品市場調査レポート:2028年までの予測

ページ数 89
価格
シングルユーザライセンス USD2,950
エンタープライズライセンス USD5,250
種別 英文調査報告書

レポート目次    お問合せ・ご注文    価格・納期について

無料サンプル

Europe CBD Products Market Research Report Forecast to 2028

The Europe CBD products market has witnessed substantial growth over the last few years and is projected to reach USD 880.56 million by the end of 2028, registering a CAGR of 9.74% during the forecast period, 2021–2028. Few significant reasons for the growth of the Europe CBD products market are growing incidences of chronic diseases and related health issues among consumers, followed by the gradual legalization of cannabinoid (CBD) across Europe. Moreover, megatrends and technological advancements in the production process and increasing R&D on cannabinoids have provided the market players an opportunity to flourish in the Europe CBD products market. However, adverse health effects associated with the consumption of cannabis are expected to hinder market growth in the next few years.
The Europe CBD products market is expected to record a CAGR of 9.74% during the forecast period. The rising prevalence of chronic diseases and related complications are the key factors driving the growth of the Europe CBD products market. The legalization of cannabinoid (CBD) in Europe is another factor contributing to the growth of the CBD products market. Moreover, megatrends and technological advancements and increasing R&D in cannabinoid Ayurveda are likely to create an opportunistic market for the players to grow and expand. However, adverse effects associated with cannabis among CBD products manufacturers create a challenging situation for the players in the Europe CBD products market.

Market Segmentation
Based on type, the Europe CBD products market has been segmented into CBD oil, CBD buds, and others. The CBD oil segment accounted for the largest market share of 81.17% in 2020.
Based on application, the Europe CBD products market has been segmented into cosmetics and medical purpose. The medical purpose segment accounted for a larger market share of 73.25% in 2020.

Regional Analysis
Europe CBD products market has been segmented, based on country, into UK, Germany, France, Spain, Italy, Switzerland, Austria, Poland, and the Rest of Europe.
Germany accounted for the largest market share of 25.07% in 2020, with a market value of USD 105.19 million; the market is expected to register a CAGR of 9.90%. The UK was the second-largest market in 2020, valued at USD 97.68 million; the market is projected to exhibit a CAGR of 9.49%. However, the market in Rest of Europe is expected to register the highest CAGR of 10.65% during the forecast period.
Major Players
The key players operating in the Europe CBD products market include CV Sciences, Inc. (US), Hempire Gardens (Spain), Essentia Pura d.o.o. (Slovenia), Cannactiva SCP (Spain), Ilesol Pharmaceuticals d.o.o. (Republic of Croatia), Hempifarm (Netherlands), Sequoia Cannabis Ltd. (Poland), Candropharm BV (Netherlands), Grünkraft AG (Switzerland) and Widora International Srl (Italy) and the market also comprises several local players.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.


目次

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 MARKET ATTRACTIVENESS ANALYSIS
1.1.1 EUROPE CBD PRODUCTS MARKET, BY TYPE
1.1.2 EUROPE CBD PRODUCTS MARKET, BY APPLICATION
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 KEY BUYING CRITERIA
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
3.4 MARKET SIZE ESTIMATION
3.5 FORECAST MODEL
3.6 LIST OF ASSUMPTIONS & LIMITATIONS
4 MARKET INSIGHTS
5 MARKET DYNAMICS
5.1 INTRODUCTION
5.2 DRIVERS
5.2.1 RISING OCCURRENCE OF CHRONIC DISEASES AND RELATED COMPLICATIONS
5.2.2 LEGALIZATION OF CANNABINOID (CBD) IN EUROPE
5.2.3 DRIVERS IMPACT ANALYSIS
5.3 RESTRAINTS
5.3.1 ADVERSE EFFECTS ASSOCIATED WITH CANNABIS
5.3.2 RESTRAINTS IMPACT ANALYSIS
5.4 OPPORTUNITIES
5.4.1 MEGATRENDS AND TECHNOLOGICAL ADVANCEMENTS
5.4.2 INCREASING R&D ON CANNABINOID
6 MARKET FACTOR ANALYSIS
6.1 VALUE CHAIN ANALYSIS
6.1.1 RESEARCH & DEVELOPMENT
6.1.2 MANUFACTURING
6.1.3 DISTRIBUTION & SALES
6.1.4 POST-SALES MONITORING
6.2 TECHNOLOGICAL INNOVATION
6.2.1 CBD HEMP FARMING
6.2.2 EXTRACTION METHODS
6.2.3 EMULSION TECHNOLOGY
6.3 COMPETITORS & PRODUCT ANALYSIS
6.3.1 INTRODUCTION
6.3.2 MARKET STRATEGY ANALYSIS
6.3.3 PRODUCT ANALYSIS
6.4 REGULATORY SCENARIO
6.5 PORTER’S FIVE FORCES MODEL
6.5.1 THREAT OF NEW ENTRANTS
6.5.2 BARGAINING POWER OF SUPPLIERS
6.5.3 THREAT OF SUBSTITUTES
6.5.4 BARGAINING POWER OF BUYERS
6.5.5 INTENSITY OF RIVALRY
6.6 NEW INVESTMENT ANALYSIS
6.7 PESTEL ANALYSIS
6.7.1 POLITICAL FACTORS
6.7.2 ECONOMICAL FACTORS
6.7.3 SOCIAL FACTORS
6.7.4 TECHNOLOGICAL FACTORS
6.7.5 ENVIRONMENTAL FACTORS
6.7.6 LEGAL FACTORS
6.8 IMPACT OF THE COVID-19 OUTBREAK ON EUROPE CBD PRODUCTS MARKET
6.8.1 OVERVIEW
6.8.2 IMPACT ON CONSUMER BEHAVIOUR
6.8.3 IMPACT ON EUROPE
6.8.4 IMPACT ON PRICING
6.8.5 IMPACT ON THE INDUSTRY
7 EUROPE CBD PRODUCTS MARKET, BY TYPE
7.1 OVERVIEW
7.1.1 EUROPE CBD PRODUCTS MARKET ESTIMATES & FORECAST, BY TYPE, 2016–2028
7.2 CBD OIL
7.2.1 CBD OIL: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2016–2028
7.3 CBD BUDS
7.3.1 CBD BUDS: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2016–2028
7.4 OTHERS
7.4.1 OTHERS: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2016–2028
8 EUROPE CBD PRODUCTS MARKET, BY APPLICATION
8.1 OVERVIEW
8.1.1 EUROPE CBD PRODUCTS MARKET ESTIMATES & FORECAST, BY APPLICATION, 2016–2028
8.2 COSMETICS
8.2.1 COSMETICS: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2016–2028
8.3 MEDICAL PURPOSE
8.3.1 MEDICAL PURPOSE: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2016–2028
9 EUROPE CBD PRODUCTS MARKET, BY COUNTRY
9.1 OVERVIEW
9.2 UK
9.3 GERMANY
9.4 FRANCE
9.5 SPAIN
9.6 ITALY
9.7 SWITZERLAND
9.8 AUSTRIA
9.9 POLAND
9.10 REST OF EUROPE
10 COMPANY PROFILES
10.1 CV SCIENCES, INC.
10.1.1 COMPANY OVERVIEW
10.1.2 FINANCIAL OVERVIEW
10.1.3 PRODUCTS OFFERED
10.1.4 SWOT ANALYSIS
10.2 HEMPIRE GARDENS
10.2.1 COMPANY OVERVIEW
10.2.2 FINANCIAL OVERVIEW
10.2.3 PRODUCTS OFFERED
10.2.4 SWOT ANALYSIS
10.3 ESSENTIA PURA D.O.O.
10.3.1 COMPANY OVERVIEW
10.3.2 FINANCIAL OVERVIEW
10.3.3 PRODUCTS OFFERED
10.3.4 SWOT ANALYSIS
10.4 CANNACTIVA SCP
10.4.1 COMPANY OVERVIEW
10.4.2 FINANCIAL OVERVIEW
10.4.3 PRODUCTS OFFERED
10.4.4 SWOT ANALYSIS
10.5 ILESOL PHARMACEUTICALS D.O.O.
10.5.1 COMPANY OVERVIEW
10.5.2 FINANCIAL OVERVIEW
10.5.3 PRODUCTS OFFERED
10.5.4 SWOT ANALYSIS
10.6 HEMPIFARM
10.6.1 COMPANY OVERVIEW
10.6.2 FINANCIAL OVERVIEW
10.6.3 PRODUCTS OFFERED
10.6.4 SWOT ANALYSIS
10.7 SEQUOIA CANNABIS LTD.
10.7.1 COMPANY OVERVIEW
10.7.2 FINANCIAL OVERVIEW
10.7.3 PRODUCTS OFFERED
10.7.4 SWOT ANALYSIS
10.8 CANDROPHARM BV
10.8.1 COMPANY OVERVIEW
10.8.2 FINANCIAL OVERVIEW
10.8.3 PRODUCTS OFFERED
10.8.4 SWOT ANALYSIS
10.9 GRÜNKRAFT AG
10.9.1 COMPANY OVERVIEW
10.9.2 FINANCIAL OVERVIEW
10.9.3 PRODUCTS OFFERED
10.9.4 SWOT ANALYSIS
10.10 WIDORA INTERNATIONAL SRL
10.10.1 COMPANY OVERVIEW
10.10.2 FINANCIAL OVERVIEW
10.10.3 PRODUCTS OFFERED
10.10.4 SWOT ANALYSIS
11 REFERENCES

LIST OF TABLES
TABLE 1 PRIMARY INTERVIEWS
TABLE 2 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 3 STATUS OF LEGALITY OF CBD IN EUROPE:
TABLE 4 EUROPE CBD PRODUCTS MARKET ESTIMATES & FORECAST, BY TYPE, 2016–2028 (USD MILLION)
TABLE 5 CBD OIL: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2016–2028 (USD MILLION)
TABLE 6 CBD BUDS: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2016–2028 (USD MILLION)
TABLE 7 OTHERS: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2016–2028 (USD MILLION)
TABLE 8 EUROPE CBD PRODUCTS MARKET ESTIMATES & FORECAST, BY APPLICATION, 2016–2028 (USD MILLION)
TABLE 9 COSMETICS: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2016–2028 (USD MILLION)
TABLE 10 MEDICAL PURPOSE: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2016–2028 (USD MILLION)
TABLE 11 EUROPE CBD PRODUCTS MARKET ESTIMATES & FORECAST, BY COUNTRY, 2016–2028 (USD MILLION)
TABLE 12 UK: CBD PRODUCTS MARKET, BY TYPE, 2016–2028 (USD MILLION)
TABLE 13 UK: CBD PRODUCTS MARKET, BY APPLICATION, 2016–2028 (USD MILLION)
TABLE 14 GERMANY: CBD PRODUCTS MARKET, BY TYPE, 2016–2028 (USD MILLION)
TABLE 15 GERMANY: CBD PRODUCTS MARKET, BY APPLICATION, 2016–2028 (USD MILLION)
TABLE 16 FRANCE: CBD PRODUCTS MARKET, BY TYPE, 2016–2028 (USD MILLION)
TABLE 17 FRANCE: CBD PRODUCTS MARKET, BY APPLICATION, 2016–2028 (USD MILLION)
TABLE 18 SPAIN: CBD PRODUCTS MARKET, BY TYPE, 2016–2028 (USD MILLION)
TABLE 19 SPAIN: CBD PRODUCTS MARKET, BY APPLICATION, 2016–2028 (USD MILLION)
TABLE 20 ITALY: CBD PRODUCTS MARKET, BY TYPE, 2016–2028 (USD MILLION)
TABLE 21 ITALY: CBD PRODUCTS MARKET, BY APPLICATION, 2016–2028 (USD MILLION)
TABLE 22 SWITZERLAND: CBD PRODUCTS MARKET, BY TYPE, 2016–2028 (USD MILLION)
TABLE 23 SWITZERLAND: CBD PRODUCTS MARKET, BY APPLICATION, 2016–2028 (USD MILLION)
TABLE 24 AUSTRIA: CBD PRODUCTS MARKET, BY TYPE, 2016–2028 (USD MILLION)
TABLE 25 AUSTRIA: CBD PRODUCTS MARKET, BY APPLICATION, 2016–2028 (USD MILLION)
TABLE 26 POLAND: CBD PRODUCTS MARKET, BY TYPE, 2016–2028 (USD MILLION)
TABLE 27 POLAND: CBD PRODUCTS MARKET, BY APPLICATION, 2016–2028 (USD MILLION)
TABLE 28 REST OF EUROPE: CBD PRODUCTS MARKET, BY TYPE, 2016–2028 (USD MILLION)
TABLE 29 REST OF EUROPE: CBD PRODUCTS MARKET, BY APPLICATION, 2016–2028 (USD MILLION)
TABLE 30 CV SCIENCES, INC.: PRODUCTS OFFERED
TABLE 31 HEMPIRE GARDENS: PRODUCTS OFFERED
TABLE 32 ESSENTIA PURA D.O.O: PRODUCTS OFFERED
TABLE 33 CANNACTIVA SCP: PRODUCTS OFFERED
TABLE 34 ILESOL PHARMACEUTICALS D.O.O.: PRODUCTS OFFERED
TABLE 35 HEMPIFARM: PRODUCTS OFFERED
TABLE 36 SEQUOIA CANNABIS LTD: PRODUCTS OFFERED
TABLE 37 CANDROPHARM BV: PRODUCTS OFFERED
TABLE 38 GRÜNKRAFT AG: PRODUCTS OFFERED
TABLE 39 WIDORA INTERNATIONAL SRL: PRODUCTS OFFERED

LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: EUROPE CBD PRODUCTS MARKET, 2020
FIGURE 3 EUROPE CBD PRODUCTS MARKET ANALYSIS, BY TYPE, 2020
FIGURE 4 EUROPE CBD PRODUCTS MARKET ANALYSIS, BY APPLICATION, 2020
FIGURE 5 EUROPE CBD PRODUCTS MARKET: STRUCTURE
FIGURE 6 KEY BUYING CRITERIA FOR CBD PRODUCTS
FIGURE 7 RESEARCH PROCESS
FIGURE 8 TOP-DOWN AND BOTTOM-UP APPROACHES
FIGURE 9 EUROPE: CBD PRODUCTS MARKET SIZE, BY COUNTRY (2020 VS. 2028)
FIGURE 10 MARKET DYNAMICS OVERVIEW
FIGURE 11 DRIVERS IMPACT ANALYSIS: EUROPE CBD PRODUCTS MARKET
FIGURE 12 RESTRAINTS IMPACT ANALYSIS: EUROPE CBD PRODUCTS MARKET
FIGURE 13 EUROPE CBD PRODUCTS MARKET: VALUE CHAIN ANALYSIS
FIGURE 14 COMPETITIVE BENCHMARKING
FIGURE 16 PESTEL ANALYSIS
FIGURE 17 EUROPE MANUKA HONEY MARKET, BY TYPE, 2020 (% SHARE)
FIGURE 18 EUROPE MANUKA HONEY MARKET, BY TYPE, 2016–2028 (USD MILLION)
FIGURE 19 EUROPE CBD PRODUCTS MARKET, BY APPLICATION, 2020 (% SHARE)
FIGURE 20 EUROPE CBD PRODUCTS MARKET, BY APPLICATION, 2016–2028 (USD MILLION)
FIGURE 21 EUROPE CBD PRODUCTS MARKET, BY COUNTRY, 2016–2028 (USD MILLION)
FIGURE 22 EUROPE CBD PRODUCTS MARKET, BY COUNTRY, 2020 (% SHARE)
FIGURE 23 CV SCIENCES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 CV SCIENCES, INC.: SWOT ANALYSIS
FIGURE 25 HEMPIRE GARDENS: SWOT ANALYSIS
FIGURE 26 ESSENTIA PURA D.O.O: SWOT ANALYSIS
FIGURE 27 CANNACTIVA SCP: SWOT ANALYSIS
FIGURE 28 ILESOL PHARMACEUTICALS D.O.O.: SWOT ANALYSIS
FIGURE 29 HEMPIFARM: SWOT ANALYSIS
FIGURE 30 SEQUOIA CANNABIS LTD: SWOT ANALYSIS
FIGURE 31 CANDROPHARM BV: SWOT ANALYSIS
FIGURE 32 GRÜNKRAFT AG: SWOT ANALYSIS
FIGURE 33 WIDORA INTERNATIONAL SRL: SWOT ANALYSIS


    お問合せフォーム

    • レポートのタイトルは自動で入ります。
    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com